![Edward Albini](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Edward Albini
Geen lopende functies
Vermogen: 533 889 $ op 30-06-2026
Profiel
Edward C.
Albini formerly worked at Genentech, Inc., as Director-Finance & International Operations, Lynx Therapeutics, Inc., as Chief Financial Officer from 1997 to 2004, Carbylan Therapeutics, Inc., as Chief Financial Officer, Itero Biopharmaceuticals, Inc., as Chief Financial Officer & Senior Vice President from 2009 to 2011, Sutro Biopharma, Inc., as Chief Financial Officer & Secretary from 2013 to 2025, Novacea, Inc., as Chief Financial Officer from 2004 to 2009, and Itero Holdings LLC, as Chief Financial Officer & Secretary from 2011 to 2016.
Mr. Albini received his undergraduate degree from Santa Clara University and Masters Business Admin degree from Haas School of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-05-2025 | 16.081 ( 0,1% ) | 533 889 $ | 30-06-2026 |
Eerdere bekende functies van Edward Albini
| Bedrijven | Functie | Einde |
|---|---|---|
| SUTRO BIOPHARMA, INC. | Financieel Directeur/CFO | 15-05-2025 |
Itero Holdings LLC
 Itero Holdings LLC Financial ConglomeratesFinance Provides investment services | Financieel Directeur/CFO | 01-01-2016 |
Itero Biopharmaceuticals, Inc.
 Itero Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for novel therapeutic proteins and antibodies | Financieel Directeur/CFO | 01-01-2011 |
Novacea, Inc.
 Novacea, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Financieel Directeur/CFO | 01-01-2009 |
Lynx Therapeutics, Inc.
 Lynx Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops genetic analysis products for the pharmaceutical, biotechnology and agriculture industries | Financieel Directeur/CFO | 01-02-2004 |
Opleiding van Edward Albini
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
38
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Lynx Therapeutics, Inc.
Lynx Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops genetic analysis products for the pharmaceutical, biotechnology and agriculture industries | Health Technology |
Carbylan Therapeutics, Inc.
 Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of molecule protease inhibitors | Health Technology |
Sutro Biopharma, Inc.
 Sutro Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new products in protein vaccines and therapeutics | Health Technology |
Itero Biopharmaceuticals, Inc.
Itero Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for novel therapeutic proteins and antibodies | Health Technology |
Santa Clara University
 Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novacea, Inc.
Novacea, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Haas School of Business
 Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Itero Holdings LLC
Itero Holdings LLC Financial ConglomeratesFinance Provides investment services | Finance |
